PCM-SABRE: a platform for benchmarking and comparing outcome prediction methods in precision cancer medicine.
Journal:
BMC bioinformatics
Published Date:
Jan 17, 2017
Abstract
BACKGROUND: Numerous publications attempt to predict cancer survival outcome from gene expression data using machine-learning methods. A direct comparison of these works is challenging for the following reasons: (1) inconsistent measures used to evaluate the performance of different models, and (2) incomplete specification of critical stages in the process of knowledge discovery. There is a need for a platform that would allow researchers to replicate previous works and to test the impact of changes in the knowledge discovery process on the accuracy of the induced models.